We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential enable/disable

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name	Webedition CMS
Purpose	This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name	econda
Purpose	Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

Statistics enable/disable

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name	econda
Purpose	Statistics

External media enable/disable

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name	YouTube
Purpose	Show YouTube content
Name	Twitter
Purpose	activate Twitter Feeds

Research

Research in Radiation Oncology

Worldwide unique stereotactic radiosurgery with scanned proton beams o treat a patien with arteriovenous malformation (AVM)

The clinical cooperation unit of the German Cancer Research Center (DKFZ) is involved in a variety of clinical, biological and technical research activities which are realized in cooperation with the University Hospital and departments of the DKFZ such as Medical Physics, Radiology and Nuclear Medicine.

One focus is currently the MR-Guidance trial (Radiat Oncol. 2014;9:12) which investigates the daily inter fractional image guidance of radiotherapy using magnetic resonance imaging (MRI) and shuttle-based patient transport. Compared to CT, MRI might offer the advantage of providing image guided radiotherapy (IGRT) without delivering an additional radiation dose to the patients. In this trial we investigate the possibility of optimization of adaptive therapy strategies due to superior soft tissue contrast of MRI.
Towards the development of treatment systems that combine MRI with linear accelerators we currently investigate the biologic effects of magnetic fields (up to 3T)on tumor cells with respect to altered electron trajectories.
Another focus of our research is the optimization of a combined therapy with ion and photon radiation. We investigate software solutions which enhance the intelligent integration of multimodal therapies.
We furthermore extensively investigate the use of stereotactic body therapy (SBRT) together with the German Society of Radiotherapy (DEGRO) and the dkfz. Here we apply ultra fast techniques (flattening filter free) and gating methods using electromagnetic markers (see CALYPSO study) are being investigated.
Within a special research field program (SFB Transregio “cognition guided surgery”) we investigate strategies to detect, predict and manage intra- and inter fractional variations in photon and ion radiotherapy.
We also perform analyses of the use of dual energy CT (DECT) for the generation of planning CTs with the aim of i) metal artefact correction, ii) extraction of a virtual native CT and iii) direct measurement of electron density.